
|Articles|January 1, 2000
The American Journal of Managed Care
- January 2000
- Volume 6
- Issue 1
Regulating the Pharmaceutical Industry: Who Really Benefits?
Author(s)Miron Stano, PhD
Advertisement
Articles in this issue
almost 26 years ago
The Impact of Health Insurance Market Reforms on Market Competitionalmost 26 years ago
Acne Vulgaris: Pathogenesis and Therapeutic Approachalmost 26 years ago
Parkinson's Disease: Focus on Management Alternativesalmost 26 years ago
The Future of Health Status Assessmentalmost 26 years ago
Can Peer-Comparison Feedback Improve Patient Functional Status?almost 26 years ago
Preventive Service Use and Medicaid Managed Care in New York CityNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
4
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
5














































